ENL-210 (Enlyton)

N/A

Report date: 2024/11/18 18:09:56

Base Information

Drug NameENL-210 (Enlyton)

Drug Alias NameResearch programme: antibody-based tumour diagnostics - EnlytonENL-210[123I]ENL -210

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionTumor-associated glycoprotein 72 inhibitors

TargetsTumor-associated glycoprotein 72

Therapy Area/IndicationsAdenocarcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEnlyton

China Registration ClassN/A

Active CompaniesEnlyton

Inactive CompaniesN/A

Active IndicationsAdenocarcinoma

Inactive IndicationsN/A

ATC CodeN/A